ORLANDO, Florida,, April 4, 2011 /PRNewswire/ -- Berg Diagnostics, a member of the Berg Pharma, Inc group of companies with Berg Biosystems and Cytotech Labs, is a Boston-based molecular diagnostics company that officially launched its molecular diagnostics services and products at AACR meeting from April 2nd - 6th in Orlando, Florida.

COVENTRY, England, April 4, 2011 /PRNewswire/ -- Lloydspharmacy, the community pharmacy chain, has revealed that one in four* (24%) of the population in Great Britain - or 11 million** adults - has taken or applied medicines which they later discovered were out of date.

Lloydspharmacy found that more than half (53%) of people do not always check the expiry date of medicines before taking them or giving them to a family member.

This is worrying considering that nearly one in six people (17%) never clear out their medicine cabinets. It presents the risk of expired medicines being used when they are no longer deemed safe. Many medicines become ineffective when they pass their expiry date and could also cause harm if they are taken by someone they were not intended for.

CRAIGAVON, Northern Ireland, April 4, 2011 /PRNewswire/ -- Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd, announce the first publication describing a potential new anti-angiogenic therapy based on a natural protein first discovered at QUB. Anti-angiogenics prevent the growth of new blood vessels in tumours and starve them of nutrients, leading to inhibition of tumour growth. 

ORLANDO, Florida, April 4, 2011 /PRNewswire/ -- Miltenyi Biotec today announces the worldwide release and availability of the MACSQuant(R) VYB, a compact, benchtop flow cytometer featuring violet, yellow, and blue lasers, and detection of 10 optical parameters. The MACSQuant VYB enables easy but sophisticated multiparametric analysis of fluorescent protein-expressing cells, stem cell characterization, and much more. With this launch, the leading provider of tools and services for cell separation and analysis technologies extends the scope and power of its flow cytometry business.

NEW ORLEANS, April 3, 2011 /PRNewswire/ -- Abbott today announced positive one-year results from 101 patients enrolled in the second phase of the ABSORB trial evaluating the world's first drug eluting Bioresorbable Vascular Scaffold (BVS) for the treatment of coronary artery disease. These results were presented during the American College of Cardiology's (ACC) 60th Annual Scientific Session and i2 Summit 2011 in New Orleans.

ORLANDO, Florida, April 4, 2011 /PRNewswire/ -- Cytotech Labs, a Boston based pharmaceutical company and member of the Berg Pharma, Inc. group along with Berg Biosystems and Berg Diagnostics today presented groundbreaking insight into seminal work performed by Nobel Laureate, Otto Warburg. The Warburg Hypothesis asserts that increased utilization of anaerobic respiration and production of lactate is negotiated by cancer cells in return for evasion of apoptosis, programmed cell death and other key characteristics of a healthy cell such as normally functioning mitochondria, the cell's energy and metabolic headquarters. This area of research has become of intense importance to medical research in the past decade for many disease states.